Correlation Between NYSE Composite and Reata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Reata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Reata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Reata Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Reata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Reata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Reata Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Reata Pharmaceuticals
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between NYSE and Reata is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Reata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reata Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Reata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reata Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Reata Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Reata Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 41.21 times less return on investment than Reata Pharmaceuticals. But when comparing it to its historical volatility, NYSE Composite is 22.87 times less risky than Reata Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Reata Pharmaceuticals is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 4,887 in Reata Pharmaceuticals on January 29, 2024 and sell it today you would earn a total of 12,349 from holding Reata Pharmaceuticals or generate 252.69% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 52.26% |
Values | Daily Returns |
NYSE Composite vs. Reata Pharmaceuticals
Performance |
Timeline |
NYSE Composite and Reata Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Reata Pharmaceuticals
Pair trading matchups for Reata Pharmaceuticals
Pair Trading with NYSE Composite and Reata Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Reata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Reata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reata Pharmaceuticals will offset losses from the drop in Reata Pharmaceuticals' long position.NYSE Composite vs. Alto Ingredients | NYSE Composite vs. Ryanair Holdings PLC | NYSE Composite vs. Yips Chemical Holdings | NYSE Composite vs. Mesa Air Group |
Reata Pharmaceuticals vs. Sarepta Therapeutics | Reata Pharmaceuticals vs. Krystal Biotech | Reata Pharmaceuticals vs. PTC Therapeutics | Reata Pharmaceuticals vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |